270 related articles for article (PubMed ID: 34755300)
61. A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications.
Aldawood FK; Andar A; Desai S
Polymers (Basel); 2021 Aug; 13(16):. PubMed ID: 34451353
[TBL] [Abstract][Full Text] [Related]
62. Marine polymeric microneedles for transdermal drug delivery.
Moniz T; Costa Lima SA; Reis S
Carbohydr Polym; 2021 Aug; 266():118098. PubMed ID: 34044917
[TBL] [Abstract][Full Text] [Related]
63. Cost-effective Fabrication of Chitosan Microneedles for Transdermal Drug Delivery.
Sadeqi A; Nejad HR; Kiaee G; Sonkusale S
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5737-5740. PubMed ID: 30441639
[TBL] [Abstract][Full Text] [Related]
64. Microneedles as the technique of drug delivery enhancement in diverse organs and tissues.
Rzhevskiy AS; Singh TRR; Donnelly RF; Anissimov YG
J Control Release; 2018 Jan; 270():184-202. PubMed ID: 29203415
[TBL] [Abstract][Full Text] [Related]
65. Dissolving microneedle patch for transdermal delivery of human growth hormone.
Lee JW; Choi SO; Felner EI; Prausnitz MR
Small; 2011 Feb; 7(4):531-9. PubMed ID: 21360810
[TBL] [Abstract][Full Text] [Related]
66. Microneedles and transdermal applications.
Sivamani RK; Liepmann D; Maibach HI
Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
[TBL] [Abstract][Full Text] [Related]
67. Microneedle Coating Methods: A Review with a Perspective.
Ingrole RSJ; Gill HS
J Pharmacol Exp Ther; 2019 Sep; 370(3):555-569. PubMed ID: 31175217
[TBL] [Abstract][Full Text] [Related]
68. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
Al-Qallaf B; Das DB
J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
[TBL] [Abstract][Full Text] [Related]
69. Electrochemical Microneedles: Innovative Instruments in Health Care.
Liao Z; Zhou Q; Gao B
Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290938
[TBL] [Abstract][Full Text] [Related]
70. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
71. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
72. Pullulan microneedle patches for the efficient transdermal administration of insulin envisioning diabetes treatment.
Fonseca DFS; Costa PC; Almeida IF; Dias-Pereira P; Correia-Sá I; Bastos V; Oliveira H; Duarte-Araújo M; Morato M; Vilela C; Silvestre AJD; Freire CSR
Carbohydr Polym; 2020 Aug; 241():116314. PubMed ID: 32507191
[TBL] [Abstract][Full Text] [Related]
73. Recent progress of 3D-printed microneedles for transdermal drug delivery.
Yang Q; Zhong W; Xu L; Li H; Yan Q; She Y; Yang G
Int J Pharm; 2021 Jan; 593():120106. PubMed ID: 33232756
[TBL] [Abstract][Full Text] [Related]
74. Fabrication, evaluation and applications of dissolving microneedles.
Zhang L; Guo R; Wang S; Yang X; Ling G; Zhang P
Int J Pharm; 2021 Jul; 604():120749. PubMed ID: 34051319
[TBL] [Abstract][Full Text] [Related]
75. Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug delivery.
Zhuang J; Rao F; Wu D; Huang Y; Xu H; Gao W; Zhang J; Sun J
Eur J Pharm Biopharm; 2020 Dec; 157():66-73. PubMed ID: 33059004
[TBL] [Abstract][Full Text] [Related]
76. Advances in the Design of Transdermal Microneedles for Diagnostic and Monitoring Applications.
Babity S; Roohnikan M; Brambilla D
Small; 2018 Dec; 14(49):e1803186. PubMed ID: 30353663
[TBL] [Abstract][Full Text] [Related]
77. Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles.
Ahad A; Raish M; Bin Jardan YA; Al-Mohizea AM; Al-Jenoobi FI
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33466845
[TBL] [Abstract][Full Text] [Related]
78. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose.
Lee K; Lee CY; Jung H
Biomaterials; 2011 Apr; 32(11):3134-40. PubMed ID: 21292317
[TBL] [Abstract][Full Text] [Related]
79. The clinical and translational prospects of microneedle devices, with a focus on insulin therapy for diabetes mellitus as a case study.
Smith F; Sabri AH; Heppel M; Fonseca I; Chowdhury F; Cheung K; Willmor S; Rawson F; Marlow M
Int J Pharm; 2022 Nov; 628():122234. PubMed ID: 36191817
[TBL] [Abstract][Full Text] [Related]
80. Microneedles for transdermal drug delivery: a minireview.
Vandervoort J; Ludwig A
Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
